The molecular mechanisms underlying LZTR1 variants highlight its distinct contribution: biallelic inactivation drives global hyperactivation associated with NS, whereas monoallelic loss causes tissue-restricted phenotypes such as schwannomatosis [35,36]. The gene discussed is LZTR1; the disease is schwannomatosis.